Marathon Asset Management LLP raised its stake in Monsanto Company (NYSE:MON) by 51.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 358,047 shares of the basic materials company’s stock after buying an additional 120,953 shares during the period. Marathon Asset Management LLP owned 0.08% of Monsanto worth $42,380,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also modified their holdings of the company. Boussard & Gavaudan Investment Management LLP increased its stake in shares of Monsanto by 471.5% in the second quarter. Boussard & Gavaudan Investment Management LLP now owns 132,525 shares of the basic materials company’s stock valued at $15,663,000 after buying an additional 109,337 shares during the last quarter. Canal Capital Management LLC purchased a new stake in shares of Monsanto during the second quarter valued at $370,000. TNB Financial purchased a new stake in shares of Monsanto during the second quarter valued at $252,000. LVM Capital Management Ltd. MI increased its stake in shares of Monsanto by 13.9% in the second quarter. LVM Capital Management Ltd. MI now owns 2,462 shares of the basic materials company’s stock valued at $291,000 after buying an additional 300 shares during the last quarter. Finally, LeJeune Puetz Investment Counsel LLC increased its stake in shares of Monsanto by 14.2% in the second quarter. LeJeune Puetz Investment Counsel LLC now owns 3,025 shares of the basic materials company’s stock valued at $358,000 after buying an additional 375 shares during the last quarter. 74.87% of the stock is currently owned by institutional investors.
Shares of Monsanto Company (MON) traded down 0.021% during trading on Thursday, reaching $117.435. 62,568 shares of the company were exchanged. Monsanto Company has a 52-week low of $97.35 and a 52-week high of $118.97. The stock has a 50-day moving average of $117.62 and a 200 day moving average of $114.03. The stock has a market capitalization of $51.59 billion, a P/E ratio of 25.364 and a beta of 1.08.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.19. The company had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The company’s revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period in the previous year, the company earned $2.17 EPS. On average, equities analysts anticipate that Monsanto Company will post $4.89 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, July 7th will be given a dividend of $0.54 per share. The ex-dividend date is Wednesday, July 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.84%. Monsanto’s payout ratio is currently 46.75%.
Several brokerages have recently weighed in on MON. UBS AG downgraded shares of Monsanto from a “positive” rating to a “neutral” rating in a report on Tuesday, June 27th. Jefferies Group LLC downgraded shares of Monsanto from a “buy” rating to a “hold” rating and set a $128.00 target price on the stock. in a report on Wednesday, July 12th. Citigroup Inc. reaffirmed a “neutral” rating and issued a $126.00 target price (up previously from $125.00) on shares of Monsanto in a report on Monday, July 10th. Vetr raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a report on Wednesday, July 12th. Finally, Barclays PLC lifted their target price on shares of Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a report on Thursday, June 29th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and nine have assigned a buy rating to the stock. Monsanto has a consensus rating of “Hold” and a consensus price target of $123.15.
In other news, EVP Steven Mizell sold 11,300 shares of the business’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the completion of the transaction, the executive vice president now directly owns 55,011 shares in the company, valued at approximately $6,522,654.27. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Janet M. Holloway sold 3,337 shares of the business’s stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $118.00, for a total value of $393,766.00. Following the transaction, the senior vice president now owns 44,405 shares of the company’s stock, valued at $5,239,790. The disclosure for this sale can be found here. Insiders have sold a total of 85,816 shares of company stock valued at $10,117,174 over the last 90 days. Corporate insiders own 0.79% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.